查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1407335

呼吸內治療設備市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按設備、最終用戶、專家、地區、競爭細分

Respiratory Endotherapy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Devices, By End User, By Specialist, By Region, By Competition
出版日期: | 出版商: TechSci Research | 英文 179 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球呼吸內治療設備市場價值為 14.5 億美元，預計到 2028 年預測期內將強勁成長，複合CAGR為 5.33%。COVID-19 大流行最初對呼吸設備市場產生了重大影響。然而，由於政府的舉措和政策以及公司為克服短缺而進行的策略發展，呼吸設備市場顯著成長。例如，2021 年 5 月，全球基金批准了 7,500 萬美元的快速通道資金，以支持印度應對 COVID-19 危機。這筆新資金幫助印度購買了氧氣機和變壓吸附（PSA）制氧廠，以滿足該國的中期醫用氧氣需求。因此，由於COVID-19病例激增，對呼吸設備的需求增加，從而推動了市場的成長。然而，隨著 COVID-19 病例的減少以及大流行加速了呼吸設備的使用，目前預計所研究的市場將在研究期間實現穩定成長。

主要市場促進因素

呼吸系統疾病盛行率上升

市場概況
預測期 2024-2028
2022 年市場規模 14.5億美元
2028 年市場規模 19.6億美元
2023-2028 年CAGR 5.33%
成長最快的細分市場 亞太地區
最大的市場 北美洲

全球呼吸系統疾病發生率不斷上升，將推動全球呼吸內科治療設備市場的擴張。慢性阻塞性肺病 (COPD)、氣喘和呼吸道感染等疾病的盛行率不斷上升，導致對先進治療介入的需求不斷增加。呼吸內治療設備在這些疾病的治療中發揮關鍵作用，提供微創和有針對性的治療。隨著全球人口老化和環境因素導致呼吸系統健康面臨挑戰，對有效且高效的內科治療解決方案的需求變得更加明顯。市場正在見證技術創新的激增，包括支氣管鏡、氣管鏡和其他內視鏡設備，這些技術創新提高了診斷準確性和治療精度。醫療保健提供者擴大採用這些設備來解決呼吸問題，從而促進了整體市場的成長。此外，患者和醫療保健專業人員對內科治療的好處（例如縮短恢復時間和改善患者治療結果）的認知不斷增強，正在推動這些設備的採用。總之，呼吸系統疾病負擔的不斷增加，加上內治療技術的進步，預計將在未來幾年促進全球呼吸內治療設備市場的顯著成長。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球呼吸內治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按設備（診斷設備、治療設備）
    • 依最終使用者（週邊血管介入、血管內介入、心臟、介入放射學、靜脈、其他）
    • 按專科醫師（醫院、診斷中心、門診手術中心）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按設備
    • 按最終用戶
    • 由專家
    • 按地區

第 6 章：北美呼吸內治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按設備（診斷設備、治療設備）
    • 依最終使用者（週邊血管介入、血管內介入、心臟、介入放射學、靜脈、其他）
    • 按專科醫師（醫院、診斷中心、門診手術中心）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲呼吸內治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按設備（診斷設備、治療設備）
    • 依最終使用者（週邊血管介入、血管內介入、心臟、介入放射學、靜脈、其他）
    • 按專科醫師（醫院、診斷中心、門診手術中心）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區呼吸內治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按設備（診斷設備、治療設備）
    • 依最終使用者（週邊血管介入、血管內介入、心臟、介入放射學、靜脈、其他）
    • 按專科醫師（醫院、診斷中心、門診手術中心）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲呼吸內治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按設備（診斷設備、治療設備）
    • 依最終使用者（週邊血管介入、血管內介入、心臟、介入放射學、靜脈、其他）
    • 按專科醫師（醫院、診斷中心、門診手術中心）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲呼吸內治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按設備（診斷設備、治療設備）
    • 依最終使用者（週邊血管介入、血管內介入、心臟、介入放射學、靜脈、其他）
    • 按專科醫師（醫院、診斷中心、門診手術中心）
    • 按國家/地區
  • MEA：國家分析
    • 南非呼吸內科治療設備
    • 沙烏地阿拉伯呼吸內科治療設備
    • 阿拉伯聯合大公國呼吸內科治療設備

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球呼吸內治療設備市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 富士膠片控股公司。
    • Business Overview
    • Product Offerings
    • Recent Developments
    • Financials (As Reported)
    • Key Personnel
    • SWOT Analysis
  • 美敦力公司
  • 強生公司。
  • 史密斯與侄子有限公司
  • 史賽克公司。
  • 奧林巴斯公司。
  • 霍亞公司。
  • 斯特里斯醫療保健。
  • 康邁德公司。
  • 波士頓科學公司。

第 16 章：策略建議

簡介目錄
Product Code: 20250

Global Respiratory Endotherapy Devices Market has valued at USD 1.45 Billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.33% through 2028. The COVID-19 pandemic had a substantial impact on the respiratory devices market initially. However, the respiratory device market grew significantly as a result of government initiatives and policies, as well as the company's strategic developments to overcome the shortfall. For instance, in May 2021, the Global Fund approved USD 75 million in fast-track funding to support India's response to the COVID-19 crisis. This new funding helped India purchase oxygen concentrators and pressure swing adsorption (PSA) oxygen plants to help meet the country's medium-term medical oxygen needs. Hence, due to the surge in COVID-19 cases, the demand for respiratory devices increased, thereby fueling the growth of the market. However, as COVID-19 cases declined and the pandemic accelerated the use of respiratory devices, the studied market is now expected to project stable growth over the studied period.

Key Market Drivers

Rising Prevalence of Respiratory Disorders

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.45 Billion
Market Size 2028USD 1.96 Billion
CAGR 2023-20285.33%
Fastest Growing SegmentAsia Pacific
Largest MarketNorth America

The escalating incidence of respiratory disorders worldwide is poised to propel the expansion of the Global Respiratory Endotherapy Devices Market. The rising prevalence of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections is fostering an increased demand for advanced therapeutic interventions. Respiratory endotherapy devices play a pivotal role in the management of these disorders, offering minimally invasive and targeted treatments. As the global population ages and environmental factors contribute to respiratory health challenges, the need for effective and efficient endotherapy solutions is becoming more pronounced. The market is witnessing a surge in technological innovations, including bronchoscopes, tracheoscopes, and other endoscopic devices, which enhance diagnostic accuracy and treatment precision. Healthcare providers are increasingly adopting these devices to address respiratory issues, contributing to the overall market growth. Furthermore, the growing awareness among patients and healthcare professionals regarding the benefits of endotherapy, such as reduced recovery times and improved patient outcomes, is driving the uptake of these devices. In conclusion, the escalating burden of respiratory disorders, coupled with technological advancements in endotherapy, is anticipated to foster significant growth in the Global Respiratory Endotherapy Devices Market in the coming years.

Rising Preferential Shift towards Minimally Invasive Procedures

The burgeoning preference for minimally invasive procedures is set to be a key driver propelling the growth of the Global Respiratory Endotherapy Devices Market. As patients increasingly seek procedures with reduced invasiveness and shorter recovery times, respiratory endotherapy devices emerge as pivotal tools in meeting these preferences. These devices, including advanced bronchoscopes and tracheoscopes, enable healthcare practitioners to perform diagnostic and therapeutic interventions with greater precision and minimal disruption to the patient. The shift towards minimally invasive techniques is driven by factors such as a desire for quicker recovery, reduced postoperative complications, and improved patient comfort. Respiratory endotherapy devices align with this trend, offering innovative solutions that cater to the evolving preferences of both patients and healthcare providers. Additionally, the continuous advancements in endoscopic technologies contribute to the growing acceptance of these devices, ensuring enhanced diagnostic capabilities and treatment efficacy. This changing landscape underscores the significance of respiratory endotherapy devices in modern healthcare, with their minimally invasive nature positioned to drive sustained market growth. As awareness of these benefits permeates the medical community, the Global Respiratory Endotherapy Devices Market is poised to expand as a result of the rising demand for less invasive respiratory procedures.

Strategic Collaborations and Partnerships

The growth trajectory of the Global Respiratory Endotherapy Devices Market is expected to be significantly influenced by strategic collaborations and partnerships within the healthcare industry. In an era of rapid technological advancements and evolving healthcare needs, collaborations between key market players, medical institutions, and research organizations become instrumental in fostering innovation and expanding market reach. Strategic alliances facilitate the pooling of expertise and resources, enabling companies to jointly invest in research and development initiatives. In the context of respiratory endotherapy devices, partnerships can lead to the creation of cutting-edge technologies, improved device designs, and more efficient treatment modalities. These collaborations also enhance market penetration by leveraging the combined strengths of the involved entities, leading to broader geographical coverage and increased accessibility of respiratory endotherapy solutions. Moreover, partnerships between device manufacturers and healthcare providers can accelerate the adoption of these devices, as integrated solutions and shared knowledge contribute to seamless clinical implementation. The collaborative approach not only addresses market challenges but also ensures a holistic response to the dynamic healthcare landscape. Ultimately, strategic collaborations and partnerships are poised to be pivotal catalysts for driving innovation, market expansion, and sustained growth in the Global Respiratory Endotherapy Devices Market.

Key Market Challenges

High Cost of Respiratory Endotherapy Devices

The high cost associated with respiratory endotherapy devices is anticipated to pose a significant impediment to the growth of the Global Respiratory Endotherapy Devices Market. The substantial financial investment required for acquiring these sophisticated medical devices can act as a deterrent for healthcare institutions, particularly in regions with constrained healthcare budgets. The intricate technology and specialized materials involved in manufacturing respiratory endotherapy devices contribute to their elevated price point, limiting accessibility for certain healthcare facilities and hindering widespread adoption. Additionally, the financial burden on patients seeking respiratory treatments may curb patient acceptance and usage. High device costs often translate to increased procedural expenses, potentially affecting reimbursement policies and posing challenges for both healthcare providers and patients. Market players need to address these cost-related concerns through strategic initiatives such as research and development aimed at cost reduction, exploring partnerships for shared investments, and advocating for favorable reimbursement policies. Mitigating the economic barriers associated with respiratory endotherapy devices is crucial for fostering market growth and ensuring broader access to these advanced medical solutions in the evolving landscape of respiratory healthcare.

Concerns Regarding Infection Control

Concerns regarding infection control represent a notable obstacle to the growth of the Global Respiratory Endotherapy Devices Market. The intricate nature of respiratory endotherapy procedures involves the introduction of devices into the respiratory system, posing a potential risk of infection transmission. Healthcare providers and patients alike are increasingly vigilant about infection control measures, especially in the context of minimally invasive procedures. The reusable nature of certain respiratory endotherapy devices raises apprehensions regarding sterilization efficacy and the possibility of cross-contamination. Stringent infection control protocols, while crucial for patient safety, may inadvertently increase operational costs for healthcare facilities as they invest in rigorous sterilization procedures and disposable components. To address these concerns and foster market growth, manufacturers must prioritize the development of devices with enhanced infection control features, such as disposable components and advanced sterilization technologies. Additionally, industry stakeholders should actively engage with regulatory bodies to establish and promote standardized infection control guidelines. Overcoming these infection control challenges is imperative for instilling confidence among healthcare providers and patients, thereby ensuring the sustained growth of the Global Respiratory Endotherapy Devices Market in an environment increasingly focused on patient safety and healthcare quality.

Key Market Trends

Advancements in Minimally Invasive Technologies

The growth trajectory of the Global Respiratory Endotherapy Devices Market is poised to be significantly steered by continual advancements in minimally invasive technologies. As medical science evolves, there is a paradigm shift towards procedures that offer reduced patient trauma, shorter recovery times, and enhanced precision. Respiratory endotherapy devices are at the forefront of this transformative trend, providing cutting-edge solutions for the diagnosis and treatment of respiratory disorders with minimal invasiveness. Innovations in endoscopic technologies, including the development of high-definition imaging and advanced navigation systems, empower healthcare practitioners to conduct intricate respiratory procedures with unprecedented clarity and accuracy. The integration of robotics and artificial intelligence further augments the capabilities of respiratory endotherapy devices, enabling more precise interventions and personalized treatment strategies. This technological evolution not only enhances the efficacy of respiratory procedures but also contributes to increased patient acceptance. As the global healthcare landscape embraces these advancements, the demand for state-of-the-art respiratory endotherapy devices is expected to rise, driving market growth. In essence, the continual refinement of minimally invasive technologies is a pivotal catalyst propelling the expansion of the Global Respiratory Endotherapy Devices Market, shaping the future of respiratory healthcare.

Integration of Artificial Intelligence (AI) and Robotics

The integration of Artificial Intelligence (AI) and robotics is poised to be a transformative driver of growth for the Global Respiratory Endotherapy Devices Market. AI and robotics bring a new dimension to respiratory interventions by enhancing precision, efficiency, and overall procedural outcomes. The application of AI algorithms enables real-time analysis of complex respiratory data, facilitating more accurate diagnostics and personalized treatment plans. This intelligent analysis assists healthcare practitioners in making informed decisions during endotherapy procedures, leading to improved patient outcomes. Incorporating robotics into respiratory endotherapy devices enhances procedural dexterity, allowing for intricate maneuvers with unparalleled precision. Robotics can navigate through the respiratory system with greater agility, offering healthcare professionals enhanced control and maneuverability during procedures. This not only reduces the complexity of interventions but also minimizes the invasiveness of the procedures, contributing to patient comfort and quicker recovery times. As the healthcare industry embraces the potential of AI and robotics, the demand for respiratory endotherapy devices equipped with these technologies is expected to soar. This integration not only addresses clinical challenges but also positions the market at the forefront of technological innovation, driving sustained growth in the Global Respiratory Endotherapy Devices Market.

Segmental Insights

Devices Insights

Based on the Devices, the Diagnostic Devices segment is anticipated to witness substantial market growth throughout the forecast period. The growth trajectory of the Global Respiratory Endotherapy Devices Market is significantly propelled by the pivotal role of diagnostic devices in shaping respiratory healthcare. Diagnostic devices play a crucial role in the early and accurate identification of respiratory disorders, setting the stage for the adoption of respiratory endotherapy solutions. Advanced diagnostic tools, such as high-resolution imaging systems and innovative sensors, provide healthcare practitioners with a comprehensive understanding of respiratory conditions, enabling targeted and personalized treatment approaches. These diagnostic devices not only contribute to early disease detection but also facilitate precise pre-procedural planning for respiratory endotherapy interventions. The seamless integration of diagnostic technologies into respiratory endotherapy devices enhances procedural accuracy, aiding healthcare professionals in navigating the respiratory system with precision during interventions. As the demand for timely and accurate respiratory diagnostics rises globally, the symbiotic relationship between diagnostic devices and respiratory endotherapy solutions becomes increasingly evident. The growth of the Global Respiratory Endotherapy Devices Market is intricately linked to the expanding landscape of advanced diagnostic capabilities, ensuring a comprehensive and effective approach to the management of respiratory disorders from diagnosis to treatment.

End User Insights

Based on the End User segment, the Peripheral Vascular Intervention segment has been the dominant force in the market. Hospital Pharmacies are poised to play a pivotal role in propelling the growth of the Global Respiratory Endotherapy Devices Market. As primary points of dispensing medications within healthcare institutions, hospital pharmacies are critical stakeholders in the effective management and treatment of infectious diseases, including those caused by Pseudomonas Aeruginosa. The demand for specialized and advanced infection treatments is significantly high within hospital settings, where patients with severe infections often receive medical care. Hospital pharmacies are crucial in ensuring the availability and timely dispensing of cutting-edge Respiratory Endotherapy Devicess, contributing directly to patient care and recovery. Furthermore, hospital pharmacies serve as hubs for healthcare professionals seeking the latest and most effective medications. As pharmaceutical companies introduce novel therapies and targeted treatments for Pseudomonas Aeruginosa infections, hospital pharmacies become key distribution channels, driving market growth through the dissemination of innovative drugs. Collaborations between pharmaceutical companies and hospital pharmacies, coupled with efficient supply chain management, are essential in meeting the rising demand for advanced infection treatments. This collaboration is anticipated to boost market growth, ensuring that hospitals have access to a diverse and effective arsenal of pharmaceutical interventions to combat Pseudomonas Aeruginosa infections effectively.

Regional Insights

North America, specifically the Respiratory Endotherapy Devices Market, dominated the market in 2022, primarily due to The North America region is positioned as a significant driver in propelling the growth of the Global Respiratory Endotherapy Devices Market. The region's advanced healthcare infrastructure, substantial investment in research and development, and a robust regulatory framework create a conducive environment for the development and commercialization of innovative infection treatments. The prevalence of Pseudomonas Aeruginosa infections in healthcare settings, coupled with a high awareness among healthcare practitioners, further fuels the demand for effective treatment solutions. North America's prominent pharmaceutical and biotechnology industry, characterized by key market players and ongoing research initiatives, contributes to the development of cutting-edge therapies. Strategic collaborations between industry stakeholders, research institutions, and healthcare providers enhance the region's capacity to address the complexities of Pseudomonas Aeruginosa infections. Moreover, the well-established reimbursement systems and high healthcare expenditure in North America provide a favorable market landscape, encouraging investments in novel treatment options. As a result, the region is poised to lead in the adoption of precision medicine, targeted therapies, and combination approaches, ultimately driving the growth of the Global Respiratory Endotherapy Devices Market. The dynamic healthcare ecosystem in North America positions it as a pivotal contributor to the market's expansion and the development of advanced solutions for combating these infections.

Key Market Players

Fujifilm Holdings Corporation.

Medtronic plc.

Johnson & Johnson.

Smith & Nephew Plc.

Stryker corporation.

Olympus corporation.

Hoya corporation.

Steris Healthcare.

Conmed corporation.

Boston Scientific corporation.

Report Scope:

In this report, the Global Respiratory Endotherapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Endotherapy Devices Market, By Devices:

  • Diagnostic Devices
  • Therapeutic Devices

Respiratory Endotherapy Devices Market, By End User:

  • Peripheral Vascular Intervention
  • Endovascular Interventions
  • Cardiac
  • Interventional Radiology
  • Venous
  • Others

Respiratory Endotherapy Devices Market, By Specialist:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers

Respiratory Endotherapy Devices Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Endotherapy Devices Market.

Available Customizations:

  • Global Respiratory Endotherapy Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Endotherapy Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
      • 5.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
      • 5.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
    • 5.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
    • 5.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Devices
    • 5.3.2 By End User
    • 5.3.3 By Specialist
    • 5.3.4 By Region

6. North America Respiratory Endotherapy Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
      • 6.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
      • 6.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
    • 6.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
    • 6.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Respiratory Endotherapy Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Devices
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Specialist
    • 6.3.2. Canada Respiratory Endotherapy Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Devices
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Specialist
    • 6.3.3. Mexico Respiratory Endotherapy Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Devices
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Specialist

7. Europe Respiratory Endotherapy Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
      • 7.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
      • 7.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
    • 7.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
    • 7.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Respiratory Endotherapy Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Devices
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Specialist
    • 7.3.2. Germany Respiratory Endotherapy Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Devices
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Specialist
    • 7.3.3. United Kingdom Respiratory Endotherapy Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Devices
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Specialist
    • 7.3.4. Italy Respiratory Endotherapy Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Devices
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Specialist
    • 7.3.5. Spain Respiratory Endotherapy Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Devices
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Specialist

8. Asia-Pacific Respiratory Endotherapy Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
      • 8.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
      • 8.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
    • 8.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
    • 8.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Respiratory Endotherapy Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Devices
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Specialist
    • 8.3.2. India Respiratory Endotherapy Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Devices
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Specialist
    • 8.3.3. Japan Respiratory Endotherapy Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Devices
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Specialist
    • 8.3.4. South Korea Respiratory Endotherapy Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Devices
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Specialist
    • 8.3.5. Australia Respiratory Endotherapy Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Devices
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Specialist

9. South America Respiratory Endotherapy Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
      • 9.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
      • 9.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
    • 9.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
    • 9.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Respiratory Endotherapy Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Devices
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Specialist
    • 9.3.2. Argentina Respiratory Endotherapy Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Devices
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Specialist
    • 9.3.3. Colombia Respiratory Endotherapy Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Devices
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Specialist

10. Middle East and Africa Respiratory Endotherapy Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
      • 10.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
      • 10.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
    • 10.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
    • 10.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Respiratory Endotherapy Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Devices
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Specialist
    • 10.3.2. Saudi Arabia Respiratory Endotherapy Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Devices
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Specialist
    • 10.3.3. UAE Respiratory Endotherapy Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Devices
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Specialist

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Respiratory Endotherapy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Fujifilm Holdings Corporation.
    • 15.1.1. Business Overview
    • 15.1.2. Product Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. Medtronic plc.
  • 15.3. Johnson & Johnson.
  • 15.4. Smith & Nephew Plc.
  • 15.5. Stryker corporation.
  • 15.6. Olympus corporation.
  • 15.7. Hoya corporation.
  • 15.8. Steris Healthcare.
  • 15.9. Conmed corporation.
  • 15.10. Boston Scientific corporation.

16. Strategic Recommendations